A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA

Christopher W Murray, David R Newell + Show 1 more

https://doi.org/10.1039/c9md90044f

Copy DOI

Journal: RSC medicinal chemistry	Publication Date: Jan 1, 2019
Citations: 48

Abstract

The winners of the Malcolm Campbell Memorial Prize for 2019 discuss the discovery of erdafitinib.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author